3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Surgical Wound Infection
2
Skin Neoplasms
1
Rectal Neoplasms
1
Pancreatic Neoplasms
1
Pancreatic Fistula
1
Leukemia, Myeloid, Acute
1
Intestinal Neoplasms
1
Duodenal Neoplasms
1
Diarrhea
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Biliary Tract Neoplasms
1
Interventions
Self Expandable Metallic Stents
3
Gemcitabine
2
Dietary Supplements
2
surufatinib
1
durvalumab
1
Yoga
1
Whey Proteins
1
Walking
1
Trace Elements
1
Saline Solution
1
Radiofrequency Ablation
1
Poly(ADP-ribose) Polymerase Inhibitors
1
Pancreaticojejunostomy
1
Immune Checkpoint Inhibitors
1
Folfox protocol
1
Exercise
1
Ethanol
1
Duodenoscopes
1
Congresses as Topic
1
Cisplatin
1
Cholangiopancreatography, Endoscopic Retrograde
1
Catheter Ablation
1
Capecitabine
1
Blood Specimen Collection
1
Bevacizumab
1
Anti-Bacterial Agents
1
Anesthesia, Local
1
Actigraphy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Biliary Tract Neoplasms
×
Anti-Bacterial Agents
×
Clear all
NCT03631173
2026-04-28
MINIMUM
Oslo University Hospital
Phase NA
Active not recruiting
201 enrolled